Abbott Laboratories buy Royal Bank of Canada
Start price
14.02.24
/
50%
€104.16
Target price
14.02.25
€119.35
Performance (%)
-4.18%
Price
30.04.24
€99.29
Summary
This prediction is currently active. With a performance of -4.18%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. A total of €0.52 was paid as dividends for this prediction. This prediction currently runs until 14.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -1.224% | -1.224% |
| iShares Core DAX® | -1.370% | -3.231% |
| iShares Nasdaq 100 | 0.172% | -3.339% |
| iShares Nikkei 225® | -0.801% | -7.859% |
| iShares S&P 500 | -0.369% | -2.979% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
0.63%
30.04.24
30.04.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
-2.67%
30.04.24
30.04.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-2.59%
30.04.24
30.04.24